Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02950077 · ClinicalTrials.gov registry record · NA
Mindfulness - Based Stress Reduction and the Relationship on Inflammation in Autoimmune Hepatitis
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02950077 is a NA study that has completed, run by Yale University. The registered enrollment target is 21 participants.
The verdict
NCT02950077, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The study is a 'pilot study' to assess the effect of a mindfulness-based stress reduction (MBSR) intervention on patients with autoimmune liver disease specifically autoimmune hepatitis type I. MBSR is a standardized intervention that has shown benefit in addiction disorders and other psychiatric disorders. There has been no study evaluating or showing the benefit of the use of MBSR in autoimmune liver disease. With published data showing the evidence of an association of stress and relapse in autoimmune hepatitis, it is hypothesized that such an intervention such as MBSR may have therapeutic effect in patients with autoimmune liver disease.
Interventions
- BEHAVIORAL mindfulness based stress reduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-04-14 |
| Est. Completion | 2020-04-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02950077
The ClinicalTrials.gov registry entry for NCT02950077 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mindfulness based stress reduction is the first listed.
NCT02950077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02950077 about?
NCT02950077 is a clinical study titled "Mindfulness - Based Stress Reduction and the Relationship on Inflammation in Autoimmune Hepatitis". The study is a 'pilot study' to assess the effect of a mindfulness-based stress reduction (MBSR) intervention on patients with autoimmune liver disease specifically autoimmune hepatitis type I. MBSR is a standardized intervention that has shown benefit in addiction disorders and other psychiatric di...
What is the current status of trial NCT02950077?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2017-04-14. Estimated completion is 2020-04-14.
What interventions are being tested in trial NCT02950077?
The interventions under investigation include: mindfulness based stress reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT02950077?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.